| [1] |
ZHANG Hanwen, HAN Ning, ZHAO Wei.
Clinical Observation of Labetalol Combined with Nifedipine in the Treatment of Gestational Hypertension
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 464-464-468.
|
| [2] |
FENG Junyi, LI Ye, ZHANG Bingchang, SHI Hui, YANG Jue.
Analysis of the Clinical Trial Research for Diabetes Drugs Based on the China Drug Trials Platform
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 492-492-496.
|
| [3] |
WU Conghui, YUE Yunxiao, LIU Huichao.
A Prospective, Randomized, Double-blind Controlled Study on the Efficacy of Tislelizumab Combined with TP Chemotherapy Regimen in the#br#
Treatment of Patients with Intermediate and Advanced Esophageal Cancer
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 477-477-481.
|
| [4] |
LU Wenna, CAI Minglong, ZHANG Chi.
A Comprehensive Clinical Evaluation of Desonide Cream in the Treatment of Eczematous Dermatoses
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 469-469-476.
|
| [5] |
HE Jianping, HUANG Minjie, ZHANG Dan.
Simultaneous Determination of Asperosaponin Ⅵ and Tanshinone ⅡA in Yigong Granules by HPLC
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 431-431-435.
|
| [6] |
LV Mengmeng, ZHANG Zhenhong, ZHANG Jinyan, NIU Wenshu.
Effect of Yuanhu Zhitong Dropping Pill Combined with Yangxue Qingnao Granules on Migraine Patients
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 482-482-486.
|
| [7] |
ZHOU Yu, ZHANG Min, YAN Liping.
Research Progress and General considerations on Nonclinical Evaluation of In Vivo Chimeric Antigen Receptor (CAR)-T Cell Therapy
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 409-409-415.
|
| [8] |
CHANG Yangtao, WANG Honghong, ZHANG Xiuhui, HAN Shiqin, REN Jinping, HAI Jin.
Microbial Limit Test and Result Analysis of Xinning Tablets in National Drug Sampling Inspection
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 447-447-452.
|
| [9] |
XUAN Yi, ZHENG Dongyan, WANG Zhe, NIU Huifang, YANG Jianwei, ZHAO Yujuan.
Study on the Construction of Technical Specifications for Risk Monitoring of Adverse Events in Hospitals
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 416-416-420.
|
| [10] |
LI Hailiang, LIU Lina, LI Yaolie, WANG Zhao, ZAN Ke, JIN Hongyu.
Research on the Determination of Aflatoxin B1 Content in Sterculiae Lychnophorae Semen by Standard Addition Method
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 436-436-440.
|
| [11] |
CHU Xianyu, XIE Qiuhong, MA Yire, PENG Xiaopeng, ZAN Ke, ZHAO Lei.
Study on the Qualitative and Quantitative Quality Control Methods of Bufonis Corium
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 421-421-425.
|
| [12] |
ZHOU Jinyu, LIU Yixian, LI Zhenyu, HUANG Dongqiang.
Research Advances of Traditional Chinese Medicine Extracts in the Treatment of Skin Pigmentation
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 453-453-459.
|
| [13] |
JIN Fengyang, YANG Fan, LIU Yuanjun, ZHAI Tingting.
Correlation Analysis of Echocardiographic Parameters, Serum Adropin Levels,and Treatment Outcomes in Patients with Dilated Cardiomyopathy
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 441-441-446.
|
| [14] |
SUN Jiao, QING Chuntang, YU bo, YUAN Feng, ZHANG Xiangfeng, WANG Dongmei.
Analysis of Drug Usage in A University Hospital Based on ABC Analysis Method
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 487-487-491.
|
| [15] |
YANG Ming, ZAN Ke, ZHAO Lei.
Research and Development Analysis on the Antibacterial Activity of Chinese Medicinal Materials
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 460-460-463.
|